Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1737-1742

  Miller, Keith ^a   Dunsmore, Colin J ^a   Fishwick, Colin W G ^a   Chopra, Ian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GENE PRODUCT; GLYCINE; LEUCINE; LINEZOLID; PROTEIN RPLC; RNA 23S; SERINE; TIAMULIN; TRANSFERASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM MUTANT; CROSS RESISTANCE; GENOTYPE; MOLECULAR MODEL; NONHUMAN; OPERON; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RIBOSOME; STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DITERPENES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MODELS, MOLECULAR; OXAZOLIDINONES; PEPTIDYL TRANSFERASES; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCUS AUREUS;

EID: 42949109089     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01015-07     Document Type: Article

References (24)

1. Bock, A., F. Turnowsky, and G. Hogenauer. 1982. Tiamulin resistance mutations in Escherichia coli. J. Bacteriol. 151:1253-1260.
2. Bosling, J., S. M. Poulsen, B. Vester, and K. S. Long. 2003. Resistance to the peptidyl transferase inhibitor tiamulin caused by mutation of ribosomal protein L3. Antimicrob. Agents Chemother. 47:2892-2896.
3. BSAC. 1991. A guide to sensitivity testing; Report of the working party on antibiotic sensitivity testing of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 27(Suppl. D):1-50.
4. Chopra, I., and K. Hacker. 1992. Uptake of minocycline by Escherichia coli. J. Antimicrob. Chemother. 29:19-25.
5. Gentry, D. R., S. F. Rittenhouse, L. McCloskey, and D. J. Holmes. 2007. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob. Agents Chemother. 51:2048-2052.
6. Jones, R. N., T. R. Fritsche, H. S. Sader, and J. E. Ross. 2006. Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci. Antimicrob. Agents Chemother. 50:2583-2586.
7. Joseph, P., J. R. Fantino, M. L. Herbaud, and F. Denizot. 2001. Rapid orientated cloning in a shuttle vector allowing modulated gene expression in Bacillus subtilis. FEMS Microbiol. Lett. 205:91-97.
8. Kloss, P., L. Xiong, D. L. Shinabarger, and A. S. Mankin. 1999. Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J. Mol. Biol. 294:93-101.
9. Kosowska-Shick, K., C. Clark, K. Credito, P. McGhee, B. Dewasse, T. Bogdanovich, and P. C. Appelbaum. 2006. Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes. Antimicrob. Agents Chemother. 50:765-769.
10. Leach, K. L., S. M. Swaney, J. R. Colca, W. G. McDonald, J. R. Blinn, L. M. Thomasco, R. C. Gadwood, D. Shinabarger, L. Xiong, and A. S. Mankin. 2007. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol. Cell 26:393.
11. Long, K. S., L. H. Hansen, L. Jakobsen, and B. Vester. 2006. Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center. Antimicrob. Agents Chemother. 50:1458-1462.
12. Long, K. S., J. Poehlsgaard, C. Kehrenberg, S. Schwarz, and B. Vester. 2006. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob. Agents Chemother. 50:2500-2505.
13. Meka, V. G., S. K. Pillai, G. Sakoulas, C. Wennersten, L. Venkataraman, P. C. DeGirolami, G. M. Eliopoulos, R. C. Moellering, and H. S. Gold. 2004. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J. Infect. Dis. 190:311-317.
14. Miller, K., A. J. O'Neill, and I. Chopra. 2002. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J. Antimicrob. Chemother. 49:925-934.
15. Miller, K., M. H. Wilcox, and I. Chopra. 2006. Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by overlapping binding regions in 23S rRNA. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C1-0944.
16. O'Neill, A. J., and I. Chopra. 2001. Use of mutator strains for characterization of novel antimicrobial agents. Antimicrob. Agents Chemother. 45:1599-1600.
17. O'Neill, A. J., J. H. Cove, and I. Chopra. 2001. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J. Antimicrob. Chemother. 47:647-650.
18. Pringle, M., J. Poehlsgaard, B. Vester, and K. S. Long. 2004. Mutations in ribosomal protein L3 and 23S rRNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol. Microbiol. 54:1295-1306.
19. Rittenhouse, S., S. Biswas, J. Broskey, L. McCloskey, T. Moore, S. Vasey, J. West, M. Zalacain, R. Zonis, and D. Payne. 2006. Selection of retapamulin, a novel pleuromutilin for topical use. Antimicrob. Agents Chemother. 50: 3882-3885.
20. Schlunzen, F., E. Pyetan, P. Fucini, A. Yonath, and J. M. Harms. 2004. Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin. Mol. Microbiol. 54:1287-1294.
21. Swaney, S. M., D. L. Shinabarger, R. D. Schaadt, J. H. Bock, J. L. Slightom, and G. E. Zurenko. 1998. Oxazolidinone resistance is associated with a mutation in the peptidyl-transferase region of 23S rRNA. Abstr. 38th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C-104.
22. Toh, S.-M., L. Xiong, C. A. Arias, M. V. Villegas, K. Lolans, J. Quinn, and A. S. Mankin. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 64:1506-1514.
23. Tsiodras, S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, R. C. Moellering, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208.
24. Wilson, P., J. A. Andrews, R. Charlesworth, R. Walesby, M. Singer, D. J. Farrell, and M. Robbins. 2003. Linezolid resistance in clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 51:186-187.